About
Dr. Gardner has spent over 25 years in academia, medicine and industry. She began her academic medical career at Stanford University, where she has held several positions including Senior Associate Dean for Education and Student Affairs and remains today as Professor of Medicine. She took a leave of absence to work at ALZA Corporation, a major drug delivery company, as a Principal Scientist, Vice President of Research and as Head ofALZA Technology Institute. She has conducted extensive research in cell biology, including gene therapy, and is widely published in the fields of cell biology and pharmacology. She has received numerous national awards and honors and serves on the Board of Directors of several public and private companies. Dr. Gardner was responsible for Essex Woodlands’ introduction to Rinat Neurosciences, which was acquired by Pfizer, Inc. in April 2006.
Investment Focus
Contact Information
Find more investors like Phyllis
Search Investors